Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
This article explains what methodology means in index construction and how it influences index composition, rebalancing, and overall performance.
5,895 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Bitcoin staged a partial recovery after a $100 billion market-wide selloff tied to tariff headlines, but traders warn...
Ethereum eyes a base-building phase near $1,800 as traders weigh a rebound versus renewed downside risk in early 2026.
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...
Crypto markets cooled as inflation persisted and rate-cut hopes dimmed. Now, a different tech story is driving big ga...
If you have $1,000? these stocks could form the core of a solid, long‑term portfolio. Learn why two consumer staples ...
Investing decisions hinge on more than headlines. This guide breaks down whether it’s time sell american express by w...
Is a $500,000 nest egg enough to retire? This guide breaks down real-world scenarios, withdrawal strategies, and inco...
XRP has fallen 26% year-to-date as the crypto market encounters new headwinds. This article breaks down the drivers b...
Volatile markets push cautious traders toward targeted bets. This piece highlights three ETFs that blend risk control...
Gold miners and memory-chip names led the losses on Tuesday as the S&P 500 slipped, while Best Buy climbed on earning...
As NVIDIA readies its GTC keynote, memory names MU and SNDK swing on speculation about a new inference chip that coul...